Lactobacillus Bacillus Microbial Composition for Poultry Pathogen Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The poultry industry faces challenges in controlling gastrointestinal pathogens like avian pathogenic Escherichia coli (APEC) in day-of-hatch birds, leading to variable gut microbiomes, disrupted intestinal homeostasis, and significant financial losses due to diseases such as colibacillosis, with existing antibiotic treatments being phased out in favor of antibiotic-free alternatives.
Innovation Solution
A direct-fed microbial composition comprising isolated Lactobacillus and Bacillus strains is developed to inhibit pathogenic bacteria, modulate the immune response, and establish a healthy gut microbiome, including strains like Lactobacillus plantarum Lp-115 and Lactobacillus salivarius Ls-33, which are administered to birds at hatch to reduce APEC populations and enhance immunological protection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to control bacterial challenges such as APEC in the hatchery, then bacterial pathogen populations are reduced, but antibiotic residues and resistance issues arise and antibiotic-free market demand cannot be met
Solution Approach 1:
The patent introduces beneficial microorganisms (Lactobacillus and Bacillus strains) as intermediary agents that mediate the control of pathogenic bacteria through competitive exclusion and immune modulation, replacing direct antibiotic action while achieving pathogen control without antibiotic residues or resistance issues
Solution Approach 2:
The patent converts the harmful presence of pathogenic bacteria into a beneficial outcome by using the immune challenge they pose to stimulate the development of the bird's immune system, while simultaneously using probiotic microorganisms to modulate this response and achieve protection without antibiotics
2Reliability
If beneficial bacteria colonization is established early in the gastrointestinal tract, then intestinal homeostasis and immunological protection are improved, but inconsistent colonization levels lead to variable gut microbiomes and reduced reliability
Solution Approach 1:
The patent applies beneficial microorganisms directly to the gastrointestinal tract at the critical early stage of hatch, establishing colonization before pathogenic bacteria can dominate, thereby ensuring consistent and reliable gut microbiome composition and intestinal homeostasis from the beginning of life
Solution Approach 2:
The patent combines multiple strains of Lactobacillus and Bacillus microorganisms into a single composition that works synergistically to establish stable colonization, improve intestinal homeostasis, and ensure consistent gut microbiome composition across different birds
3Adaptability or versatility
If pathogenic bacterial populations are allowed to establish, then natural colonization processes occur, but APEC populations can translocate to the bloodstream and cause colibacillosis with high mortality rates
Solution Approach 1:
The patent applies beneficial microorganisms in advance to occupy ecological niches and compete for resources, preventing pathogenic bacteria from establishing significant populations before they can cause harm, thereby blocking the pathway to colibacillosis while allowing natural colonization processes to proceed in a controlled manner
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microbial composition effectively reduces APEC and Clostridium perfringens levels in the gastrointestinal tract, improves bird performance, and decreases mortality and disease incidence without the use of antibiotics, promoting a balanced gut microbiome and immune system development.
Implementation Method 1
provide a competitive environment to exclude or reduce the APEC populations
Implementation Method 2
inhibit pathogenic bacterial populations
Implementation Method 3
modulate an immune response in a bird
Data Source
AI summary
This disclosure relates generally to a microbial treatment for poultry. More particularly, the disclosure relates to a direct fed microbial composition including one or more lactic acid bacteria strains in combination with one or more Bacillus bacteria strains configured to inhibit gastrointestinal pathogens in a bird. A method of use is also disclosed herein.


